0001964306-24-000193.txt : 20240422 0001964306-24-000193.hdr.sgml : 20240422 20240422160957 ACCESSION NUMBER: 0001964306-24-000193 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240422 DATE AS OF CHANGE: 20240422 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823562771 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 24861288 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MOORE TIMOTHY L. CENTRAL INDEX KEY: 0001669207 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O KITE PHARMA, INC. STREET 2: 2225 COLORADO AVE. CITY: SANTA MONICA STATE: CA ZIP: 90404 144 1 primary_doc.xml 144 0001669207 XXXXXXXX LIVE 0001737287 Allogene Therapeutics, Inc. 001-38693 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700 MOORE TIMOTHY L. Officer Common Stock Merrill Lynch

225 Liberty Street Floor 37 New York NY 10281

17360 60189.64 169091992 04/22/2024 NASDAQ Common Stock 04/20/2024 Vesting of restricted stock unit award Allogene Therapeutics, Inc. N 17360 04/20/2024 Granted as part of issuer equity compensation plan Y 04/22/2024 TIMOTHY MOORE